AbCellera Biologics Inc. filed SEC Form 8-K: Results Of Operations And Financial Condition On March 29, 2021, Abcellera Biologics Inc, Regulation Fd Disclosure   In Connection With Its Earnings Call On March 29, 2021 To Discuss Its Results For The Quarter And Year Ended December 31, 2020, The Company Will Utilize A Corporate Presentation, A Copy Of Which Is Furnished Herewith As Exhibit 99